[1] Devivo MJ:Epidemiology of traumatic spinal cord injury: trends and future implications. Spinal Cord 2012, 50(5):365-72.
[2] Malmqvist L, Biering-Sorensen T, Bartholdy K, Krassioukov A, Welling KL, Svendsen JH, Kruse A, Hansen B, Biering-Sorensen F: Assessment of autonomic function after acute spinal cord injury using heart rate variability analyses. Spinal Cord 2015, 53(1):54-58.
[3] Alizadeh A, Dyck SM, Kataria H, Shahriary GM, Nguyen DH, Santhosh KT, Karimi-Abdolrezaee S: Neuregulin-1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury. Glia 2017, 65(7):1152-1175.
[4] Liu S, Chen Z: Employing Endogenous NSCs to Promote Recovery of Spinal Cord Injury. Stem Cells Int 2019, 2019:1958631.
[5] Rosich K, Hanna BF, Ibrahim RK, Hellenbrand DJ, Hanna A: The Effects of Glial Cell Line-Derived Neurotrophic Factor after Spinal Cord Injury. J Neurotrauma 2017, 34(24):3311-3325.
[6] Amanat M, Vaccaro AR: Reducing alpha-synuclein in spinal cord injury: A new strategy of treatment. J Neurosci Res 2019, 97(7):729-732.
[7] Goedert M: NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Abeta, tau, and alpha-synuclein. Science 2015, 349(6248):1255555.
[8] Rocha EM, De Miranda B, Sanders LH: Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Neurobiol Dis 2018, 109(Pt B):249-257.
[9] Feng GY, Liu J, Wang YC, Wang ZY, Hu Y, Xia QJ, Xu Y, Shang FF, Chen MR, Wang F et al: Effects of Alpha-Synuclein on Primary Spinal Cord Neurons Associated with Apoptosis and CNTF Expression. Cell Mol Neurobiol 2017, 37(5):817-829.
[10] Wang H, Yu Q, Ding X, Hu X, Hou K, Liu X, Nie S, Xie M: RNA-seq based elucidation of mechanism underlying Ganoderma atrum polysaccharide induced immune activation of murine myeloid-derived dendritic cells. Journal of Functional Foods 2019, 55:104-116.
[11] Ballouz S, Gillis J: AuPairWise: A Method to Estimate RNA-Seq Replicability through Co-expression. PLoS Comput Biol 2016, 12(4):e1004868.
[12] Balta EA, Wittmann MT, Jung M, Sock E, Haeberle BM, Heim B, von Zweydorf F, Heppt J, von Wittgenstein J, Gloeckner CJ et al: Phosphorylation Modulates the Subcellular Localization of SOX11. Front Mol Neurosci 2018, 11:211.
[13] Flores-Cuadrado A, Saiz-Sanchez D, Mohedano-Moriano A, Martinez-Marcos A, Ubeda-Banon I: Neurodegeneration and contralateral alpha-synuclein induction after intracerebral alpha-synuclein injections in the anterior olfactory nucleus of a Parkinson's disease A53T mouse model. Acta Neuropathol Commun 2019, 7(1):56.
[14] Braak H, Del Tredici K: Neuroanatomy and pathology of sporadic Parkinson's disease. Adv Anat Embryol Cell Biol. 2009, 201:1-119.
[15] Xiang X, Yu Y, Tang X, Chen M, Zheng Y, Zhu S: Transcriptome Profile in Hippocampus During Acute Inflammatory Response to Surgery: Toward Early Stage of PND. Front Immunol 2019, 10:149.
[16] Anglister L, Cherniak M, Lev-Tov A: Ascending pathways that mediate cholinergic modulation of lumbar motor activity. J Neurochem 2017, 142 Suppl 2:82-89.
[17] Uchihara T, Giasson BI: Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 2016, 131(1):49-73.
[18] Sharrad DF, de Vries E, Brookes SJ: Selective expression of alpha-synuclein-immunoreactivity in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig rectum and human colon. J Comp Neurol 2013, 521(3):657-676.
[19] Skup M, Gajewska-Wozniak O, Grygielewicz P, Mankovskaya T and Czarkowska-Bauch J: Different effects of spinalization and locomotor training of spinal animals on cholinergic innervation of the soleus and tibialis anterior motoneurons. Eur. J. Neurosci 2012, 36, 2679–2688.
[20] Wieckowska A, Gajewska-Wozniak O, Glowacka A, Ji B, Grycz K, Czarkowska-Bauch J, Skup M: Spinalization and locomotor training differentially affect muscarinic acetylcholine receptor type 2 abutting on alpha-motoneurons innervating the ankle extensor and flexor muscles. J Neurochem 2018, 147(3):361-379.
[21] Wada N, Shimizu T, Takai S, Shimizu N, Tyagi P, Kakizaki H, Yoshimura N: Combinational effects of muscarinic receptor inhibition and beta3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury. Neurourol Urodyn 2017, 36(4):1039-1045.
[22] Paulose CS, John PS, Chinthu R, Akhilraj PR, Anju TR: Spinal cord regeneration by modulating bone marrow with neurotransmitters and Citicholine: Analysis at micromolecular level. Biomed J 2017, 40(2):94-100.
[23] Ettle B, Kerman BE, Valera E, Gillmann C, Schlachetzki JC, Reiprich S, Buttner C, Ekici AB, Reis A, Wegner M et al: alpha-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy. Acta Neuropathol 2016, 132(1):59-75.
[24] Liu Q, Emadi S, Shen JX, Sierks MR, Wu J: Human alpha4beta2 nicotinic acetylcholine receptor as a novel target of oligomeric alpha-synuclein. PLoS One 2013, 8(2):e55886.
[25] Quik M, Wonnacott S: alpha6beta2* and alpha4beta2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease. Pharmacol Rev 2011, 63(4):938-966.
[26] Kitamura Y, Kanemoto E, Sugimoto M, Machida A, Nakamura Y, Naito N, Kanzaki H, Miyazaki I, Asanuma M, Sendo T: Influence of nicotine on doxorubicin and cyclophosphamide combination treatment-induced spatial cognitive impairment and anxiety-like behavior in rats. Naunyn Schmiedebergs Arch Pharmacol 2017, 390(4):369-378.
[27] Kimura M, Hayashida K, Eisenach JC, Saito S, Obata H:Relief of hypersensitivity after nerve injury from systemic donepezil involves spinal cholinergic and γ-aminobutyric acid mechanisms. Anesthesiology 2013,118(1):173-80.
[28] Ayanlaja AA, Xiong Y, Gao Y, Ji G, Tang C, Abdikani Abdullah Z, Gao D: Distinct Features of Doublecortin as a Marker of Neuronal Migration and Its Implications in Cancer Cell Mobility. Front Mol Neurosci 2017, 10:199.
[29] Li DJ, Fu H, Tong J, Li YH, Qu LF, Wang P, Shen FM: Cholinergic anti-inflammatory pathway inhibits neointimal hyperplasia by suppressing inflammation and oxidative stress. Redox Biol 2018, 15:22-33.
[30] Kiguchi N, Kobayashi D, Saika F, Matsuzaki S, Kishioka S: Inhibition of peripheral macrophages by nicotinic acetylcholine receptor agonists suppresses spinal microglial activation and neuropathic pain in mice with peripheral nerve injury. J Neuroinflammation 2018, 15(1):96.
[31] Hoover DB: Cholinergic modulation of the immune system presents new approaches for treating inflammation. Pharmacol Ther 2017, 179:1-16.
[32] Maurer SV, Williams CL: The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells. Front Immunol 2017, 8:1489.
[33] Liu Z, Wang L, Lv Z, Zhou Z, Wang W, Li M, Yi Q, Qiu L, Song L: The Cholinergic and Adrenergic Autocrine Signaling Pathway Mediates Immunomodulation in Oyster Crassostrea gigas. Front Immunol 2018, 9:284.
[34] Jiang W, St-Pierre S, Roy P, Morley BJ, Hao J, Simard AR: Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis. J Immunol 2016, 196(5):2095-2108.
[35] Mingarro I, von Heijne G, Whitley P: Membrane-protein engineering.Trends Biotechnol 1997,15(10):432-7.
[36] Squair JW, Ruiz I, Phillips AA, Zheng MMZ, Sarafis ZK, Sachdeva R, Gopaul R, Liu J, Tetzlaff W, West CR et al: Minocycline Reduces the Severity of Autonomic Dysreflexia after Experimental Spinal Cord Injury. J Neurotrauma 2018, 35(24):2861-2871.
[37] Basso DM, Beattie MS, Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995,12:1-21.
[38] Li B, Dewey CN: RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 2011;12:323.
[39] Xie C, Mao X, Huang J, Ding Y, Wu J, Dong S, et al: KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res 2011;39:W316-22.
[40] Sahinkaya FR, Milich LM, McTigue DM: Changes in NG2 cells and oligodendrocytes in a new model of intraspinal hemorrhage. Exp Neurol 2014, 255:113-126.
[41] Haggerty AE ,Marlow MM ,Oudega M : Extracellular matrix components as therapeutics for spinal cord injury. Neurosci Lett 2017 Jun 23;652:50-55.
[42] Mehra S, Ghosh D, Kumar R, Mondal M, Gadhe LG, Das S, Anoop A, Jha NN, Jacob RS, Chatterjee D et al: Glycosaminoglycans have variable effects on α-synuclein aggregation and differentially affect the activities of the resulting amyloid fibrils. J Biol Chem 2018,293(34):12975-12991.
[43] Dias DO, Kim H, Holl D, Werne Solnestam B, Lundeberg J, Carlén M, Göritz C, Frisén J: Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. Cell 2018 ,173(1):153-165.
[44] Perfeito R, Lázaro DF, Outeiro TF, Rego AC:Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells. Mol Cell Neurosci, 2014, 62:51-9.
[45] Luk KC:Oxidative stress and α-synuclein conspire in vulnerable neurons to promote Parkinson's disease progression. J Clin Invest,2019 ,130:3530-3531.
[46] Musgrove RE, Helwig M, Bae EJ, Aboutalebi H, Lee SJ, Ulusoy A, Di Monte DA: Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer. J Clin Invest, 2019,130:3738-3753.
[47] Ulusoy A, Phillips RJ, Helwig M, Klinkenberg M, Powley TL, Di Monte DA: Brain-to-stomach transfer of α-synuclein via vagal preganglionic projections. Acta Neuropathol, 2017 ,133(3):381-393.
[48] Pepeu G, Grazia Giovannini M:The fate of the brain cholinergic neurons in neurodegenerative diseases.Brain Res, 2017 ,1670:173-184.
[49] Tozzi A, de Iure A, Bagetta V, Tantucci M, Durante V, Quiroga-Varela A, Costa C, Di Filippo M, Ghiglieri V, Latagliata EC et al: Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit. Biol Psychiatry,2016,79(5):402-414.
[50] Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. BIOINFORMATICS,2009;25:1105-11.
[51] Love M I, Huber W, Anders S: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome biology, 2014, 15(12): 550.